Functional Avidity of Tumor Antigen-Specific CTL Recognition Directly Correlates With the Stability of MHC/Peptide Multimer Binding to TCR

Journal of Immunology - United States
doi 10.4049/jimmunol.168.3.1167
Full Text
Abstract

Available in full text

Date
Authors
Publisher

The American Association of Immunologists

Related search

Mechano-Regulation of Peptide-MHC Class I Conformations Determines TCR Antigen Recognition

Molecular Cell
Cell BiologyMolecular Biology
2019English

Relating TCR-peptide-MHC Affinity to Immunogenicity for the Design of Tumor Vaccines

Journal of Clinical Investigation
Medicine
2006English

Regulatory T Cells and Co‐evolution of Allele‐specific MHC Recognition by the TCR

Scandinavian Journal of Immunology
MedicineImmunology
2019English

Structural and Energetic Evidence for Highly Peptide-Specific Tumor Antigen Targeting via Allo-MHC Restriction

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2011English

Targeting Cancers Through TCR-peptide/MHC Interactions

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2019English

Competitive Inhibition in Vivo and Skewing of the T Cell Repertoire of Antigen-Specific CTL Priming by an Anti-Peptide-MHC Monoclonal Antibody

Journal of Immunology
AllergyImmunology
2001English

Loss of Tapasin in Human Lung and Colon Cancer Cells and Escape From Tumor-Associated Antigen-Specific CTL Recognition

OncoImmunology
OncologyAllergyImmunology
2017English

Molecular Mechanism of MART-1 + /A*0201 + Human Melanoma Resistance to Specific CTL-Killing Despite Functional Tumor–CTL Interaction

Cancer Research
Cancer ResearchOncology
2010English

Levels of Specific Peptide-Hla Class I Complex Predicts Tumor Cell Susceptibility to CTL Killing

Journal of Immunology
AllergyImmunology
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy